S&P Futures
3,990.00 +7.00 (+0.18%) Dow Futures
32,509.00 +53.00 (+0.16%) Nasdaq Futures
12,696.00 +7.50 (+0.06%) Russell 2000 Futures
1,769.00 +8.30 (+0.47%) Crude Oil
67.29 -0.35 (-0.52%) Gold
1,984.60 +1.80 (+0.09%)
Semler Scientific, Inc. (SMLR)
After hours:
- PR Newswire
Semler to Report Fourth Quarter and Year End 2022 Financial Results and Host Conference Call on March 21, 2023
Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2022, after the close of U.S. financial markets on Tuesday, March 21, 2023. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Andrew Weinstein, se
- PR Newswire
Semler Announces Clinical Study Published Using QuantaFlo® as an Aid for Diagnosis of Heart Dysfunction in the Primary Care Setting
Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers (HCPs), today announced the publication of a study in the peer-reviewed Journal of Preventive Medicine with data supporting the use of QuantaFlo as an aid to measure hemodynamics related to heart dysfunction (HD). Notably, the study showed a statistically significant correlation (p
- PR Newswire
Major Clinical Study Using Semler's QuantaFlo® for Medicare Advantage Beneficiaries, Demonstrates that National, In-Home Screening for Peripheral Artery Disease (PAD) is Feasible
Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that a study was published in the peer-reviewed AJPM Focus with data collected using the company's QuantaFlo® PAD test under real-world conditions, illustrating the benefits of PAD in-home screening. AJPM Focus is the official open access journal jointly launched this year by both The American College of Preventive Medi
